Clinical Trial

Acostream Use in Patients With High Risk and Intermediate-risk Acute Pulmonary Embolism

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 27, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The registry is to evaluate the safety and feasibility of catheter-directed aspiration for patients with high-risk and intermediate-high-risk pulmonary embolism using Acostream.
Trial Details
NCT Number NCT06946732
Lead Sponsor RenJi Hospital
Collaborators: Xiamen Cardiovascular Hospital, Xiamen University, Nantong University Affiliated Hospital, Chengdu University of Traditional Chinese Medicine, Shanghai No.1 Hospital, First Affiliated Hospital of Fujian Medical University, Jinhua Central Hospital
Conditions Pulmonary Embolism (PE)
Enrollment 127 participants
Start Date 2025-04-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-27